Application of Insulin Medication Management to Improve Blood Glucose Stability in Patients with Type I Diabetes Mellitus

Aji Setya Guna Darma; Idramsyah .Idramsyah

doi:10.37287/ijghr.v6iS5.4211

Aji Setya Guna Darma Poltekkes Kemenkes Bengkulu
Idramsyah .Idramsyah Poltekkes Kemenkes Bengkulu

DOI: https://doi.org/10.37287/ijghr.v6iS5.4211

Keywords: blood glucose, diabetes mellitus, insulin therapy, medication management

Abstract

People with type 1 diabetes mellitus need insulin therapy to maintain blood glucose stability and improve their quality of life. Nurses have an important role in insulin medication management interventions to achieve therapeutic goals. Objective: This study aims to provide an overview of the application of evidence-based practice nursing activities for developing insulin medication management interventions to improve blood glucose stability in patients with type I diabetes mellitus. Method: This descriptive case study uses a nursing process approach carried out on one young person with type 1 diabetes mellitus at the Regional General Hospital (RSUD) Dr. M Yunus Bengkulu. The nursing process is carried out for three days while the patient is treated in the internal medicine room. Data were collected through interviews and observation. Results: Nursing activities started with assessing the patient's nutritional and fluid needs and continued to data analysis. The analyzed data shows that >80% of the major and minor data are listed in the nursing diagnosis guidelines, namely the Indonesia Nursing Diagnostic Standards (SDKI). From the data obtained, the diagnosis that can be raised is the instability of blood glucose levels with the criteria of nursing outcomes of the level of knowledge with increased expectations. On the last day of the nursing evaluation, there was an increase in the level of knowledge from moderate to increase in the respondents. Conclusions: Applying nursing activity development to insulin medication management intervention effectively achieves blood glucose stability in patients with type 1 diabetes mellitus.

References

Ahuja, A., & Gupta, J. (2020). Diabetes Silent Killer: Medical focus on Food Replacement and Dietary Plans Antimicrobial activity of herb View project. September. https://doi.org/10.15515/abr.0976-4585.11.5.128135

Bahendeka, S., Kaushik, R., Swai, A. B., Otieno, F., Bajaj, S., Kalra, S., Bavuma, C. M., & Karigire, C. (2019). EADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management. Diabetes Therapy, 10(2), 341–366. https://doi.org/10.1007/s13300-019-0574-x

Bielka, W., Przezak, A., Molęda, P., Pius-Sadowska, E., & Machaliński, B. (2024). Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovascular Diabetology, 23(1), 1–13. https://doi.org/10.1186/s12933-024-02145-x

Boonpattharatthiti, K., Saensook, T., Neelapaijit, N., Sakunrag, I., Krass, I., & Dhippayom, T. (2024). The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis. In Research in Social and Administrative Pharmacy (Vol. 20, Issue 3). Elsevier Inc. https://doi.org/10.1016/j.sapharm.2023.11.009

Botero, J. F., Vásquez, L. M., Blanco, V. M., Cuesta, D. P., Ramírez-Rincón, A., Bedoya, J., & Palacio, A. (2021). The effectiveness of a comprehensive diabetes program for glycemic control and adherence, and the selection of candidates for sensor-augmented insulin pump therapy. Endocrinología, Diabetes y Nutrición (English Ed.), 68(10), 735–740. https://doi.org/10.1016/j.endien.2021.12.002

Farsaei, S., Radfar, M., Heydari, Z., Abbasi, F., & Qorbani, M. (2014). Insulin adherence in patients with diabetes: Risk factors for injection omission. Primary Care Diabetes, 8(4), 338–345. https://doi.org/10.1016/j.pcd.2014.03.001

Fukao, T., Mitchell, G., Sass, J. O., Hori, T., Orii, K., & Aoyama, Y. (2014). Ketone body metabolism and its defects. Journal of Inherited Metabolic Disease, 37(4), 541–551. https://doi.org/10.1007/s10545-014-9704-9

Golding, J. A., Yong, E. S. T., Hope, S. V., Wright, J. E., Levett, T. J., & Chakera, A. J. (2024). Type 1 diabetes and frailty: A scoping review. Diabetic Medicine, 41(8), 1–16. https://doi.org/10.1111/dme.15344

Gumilas, N. S. A., Harini, I. M., Samodro, P., & Ernawati, D. A. (2021). Mmas-8 score assessment of therapy adherence to glycemic control of patients with type 2 diabetes mellitus, tanjung purwokerto, Java, Indonesia (October 2018). Southeast Asian Journal of Tropical Medicine and Public Health, 52(3), 359–370.

Haddadi, D., Rosolowsky, E., Pacaud, D., McKeen, J., Young, K., Madrick, B., Domaschuk, L., Sargious, P., Conroy, S., & Senior, P. A. (2021). Revision of Alberta’s Provincial Insulin Pump Therapy Criteria for Adults and Children With Type 1 Diabetes: Process, Rationale and Framework for Evaluation. Canadian Journal of Diabetes, 45(3), 228-235.e4. https://doi.org/10.1016/j.jcjd.2020.08.097

Huang, H. T. D., & Hung, S. T. A. (2018). Investigating the strategic behaviors in integrated speaking assessment. System, 78, 201–212. https://doi.org/10.1016/j.system.2018.09.007

Indramsyah, I., & Novira, D. (2023). Studi Fenomenologi Persepsi Pasien dan Keluarga tentang Luka Kaki Diabetes. Health Information : Jurnal Penelitian, 15(3), e970. https://doi.org/10.36990/hijp.v15i3.970

Martinez-Perez, P., Orozco-Beltrán, D., Pomares-Gomez, F., Hernández-Rizo, J. L., Borras-Gallen, A., Gil-Guillen, V. F., Quesada, J. A., Lopez-Pineda, A., & Carratala-Munuera, C. (2021). Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in type 2 diabetes patients in Spain. Atencion Primaria, 53(2), 101942. https://doi.org/10.1016/j.aprim.2020.09.007

PERKENI. (2021). Pedoman Petunjuk Praktis Terapi Insulin Pada Pasien Diabetes Mellitus 2021. Pb Perkeni, 1–70.

Putri, H. L., Malini, H., & Maisa, E. A. (2023). Utilization Of Educational Videos In Increasing Knowledge And Skills Of Insulin Pen Injection In Type 2 Diabetes Mellitus Patients : Literature Review. 7, 616–625.

Saibi, Y., Romadhon, R., & Nasir, N. M. (2020). Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Jakarta Timur. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 6(1), 94–103. https://doi.org/10.22487/j24428744.2020.v6.i1.15002

Schaper, N. C., van Netten, J. J., Apelqvist, J., Bus, S. A., Hinchliffe, R. J., & Lipsky, B. A. (2020). Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews, 36(S1), 1–10. https://doi.org/10.1002/dmrr.3266

Simamora, S., Sarmadi, Mona Rahmi Rulianty, & Ferawati Suzalin. (2021). Peduli Penggunaan Insulin. Dinamisia : Jurnal Pengabdian Kepada Masyarakat, 5(3), 638–644. https://doi.org/10.31849/dinamisia.v5i3.4823

Skriver, L. K. L., Nielsen, M. W., Walther, S., Nørlev, J. D., & Hangaard, S. (2023). Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review. Journal of Diabetes and Its Complications, 37(10), 108596. https://doi.org/10.1016/j.jdiacomp.2023.108596

Soelistijo, S. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Global Initiative for Asthma, 46. www.ginasthma.org.

Sophausvaporn, P., Boonhong, J., & Sahakitrungruang, T. (2023). The Prevalence of Diabetic Peripheral Neuropathy in Youth with Diabetes Mellitus. Annals of Pediatric Endocrinology and Metabolism, 28(1), 20–25. https://doi.org/10.6065/apem.2244092.046

Tai, C.-H., Hsieh, T.-C., Lee, R.-P., & Lo, S.-F. (2021). Prevalence and Medical Resource of Patients with Diabetic Foot Ulcer: A Nationwide Population-Based Retrospective Cohort Study for 2001–2015 in Taiwan. International Journal of Environmental Research and Public Health, 18(4), 1891. https://doi.org/10.3390/ijerph18041891

Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., Hoegfeldt, C. A., Elise Powe, C., Immanuel, J., Karuranga, S., Divakar, H., Levitt, Na. A., Li, C., Simmons, D., & Yang, X. (2022). IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Research and Clinical Practice, 183, 109050. https://doi.org/10.1016/j.diabres.2021.109050

Webber, S. (2013). International Diabetes Federation. Diabetes Research and Clinical Practice, 102(2), 147–148. https://doi.org/10.1016/j.diabres.2013.10.013

Wilson, L. M., & Castle, J. R. (2020). Recent Advances in Insulin Therapy. Diabetes Technology & Therapeutics, 22(12), 929–936. https://doi.org/10.1089/dia.2020.0065

Zarse, E., Knoll, M. M., Halpin, K., Thompson, M., Williams, D. D., Tallon, E. M., Kallanagowdar, G., & Tsai, S. (2024). Recognizing Complications in Youth With Diabetes Admitted With Diabetic Ketoacidosis Versus Hyperglycemic Hyperosmolar State. Journal of Pediatric Health Care. https://doi.org/10.1016/j.pedhc.2023.12.012

Zhang, Y., Lazzarini, P. A., McPhail, S. M., van Netten, J. J., Armstrong, D. G., & Pacella, R. E. (2020). Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care, 43(5), 964–974. https://doi.org/10.2337/dc19-1614.